CSF3 and metabolic dysfunction-associated steatotic liver disease: Conventional short acting G-CSF 30 μg/kg (twice a week for one month, M+G group) and long acting G-CSF (once in 9th week) 30 μg/kg was administered in MCD induced NAFLD model.